Christopher K. Murray, CHIEF TECHNICAL OPERATIONS at Blueprint Medicines Corp (BPMC), sold 3,704 shares at $45.71 ($169K) on 2023-03-06, disclosed to the SEC on 2023-03-08.
Seasonal sale ($169k) by CHIEF TECHNICAL OPERATIONS — this insider has traded BPMC in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.30 | 46 | $2K | 1.2% |
| 2 | $45.71 | 1,829 | $84K | 49.4% |
| 3 | $45.71 | 1,829 | $84K | 49.4% |
| Total | $45.69 avg | 3,704 | $169K | 100% |
| Filing → |
| BPMC | SELL | 2024-03-01 | $500K | — | Filing → |
| BPMC | SELL | 2023-12-11 | $375K | — | Filing → |
| BPMC | SELL | 2023-12-06 | $43K | — | Filing → |